ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹69 Cr | ₹55 Cr | ₹109 Cr | ₹63 Cr | ₹100 Cr |
What is the latest Contingent Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹55 Cr |
| Mar2023 | ₹109 Cr |
| Mar2022 | ₹63 Cr |
| Mar2021 | ₹100 Cr |
How is Contingent Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹69 Cr | 26.15 | |
| Mar2024 | ₹55 Cr | -50.00 | |
| Mar2023 | ₹109 Cr | 73.74 | |
| Mar2022 | ₹63 Cr | -37.42 | |
| Mar2021 | ₹100 Cr | - | |
Compare Contingent Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹14,975.0 Cr | 3.1% | 1.2% | -25% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 3.1% |
1.2% |
-25% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses